YORK, Pa., Dec. 11, 2014 /PRNewswire/ -- Unilife Corporation (NASDAQ: UNIS and ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced the appointment of Kevin Sellers, a veteran marketing and communications executive at Intel Corporation, to the post of Senior Vice President, Marketing and Communications. Sellers will report to Unilife Chairman and CEO Alan Shortall, with responsibility for investor relations, global marketing and public relations
Prior to joining Unilife, Sellers spent 23 years at Intel Corporation, a company with a $175B market capitalization and over $52B in annual revenue, in a variety of key marketing, communications and finance functions.
For several years at Intel, Sellers served as Vice President of Investor Relations where he was recognized multiple times as the Best IR Professional in his industry by Institutional Investor Magazine and also led Intel to receiving the Best Nasdaq-listed Company for Investor Relations in 2012.
Sellers was most recently the Vice President of Creative Services and Digital Marketing where he had responsibility for Intel's global advertising and digital marketing strategy. While in this role, he championed the award-winning 'Look Inside' campaign garnering numerous industry honors including an unprecedented five Cannes Lions Awards for creative excellence. He also led the overhaul of Intel's domain site, Intel.com, elevating it to become one of the top 20 corporate websites in 2013 as listed by Web Globalization Report. Sellers also served in several other strategic roles at Intel including Director of Corporate Brand Strategy and Director of Marketing at Intel Japan based in Tokyo.
"Unilife is a special company and I am excited to be joining them at this point in my career," said Sellers. "I am incredibly impressed with the talented technical and management team at Unilife and share their passion to dramatically improve healthcare by enhancing the delivery of injectable therapies. I look forward to helping Alan and the team in establishing the strong brand and corporate reputation the company deserves."
Mr. Alan Shortall, Chairman and CEO of Unilife, said: "Kevin's 23 years at Intel, another high-tech industry leader, will support our rapid growth trajectory and strongly complement the depth and quality of our own high-performance team. Kevin's passion and expertise will create significant value across many business areas including marketing and brand management. One initial area of focus will be in utilizing his significant experience in investor relations to further strengthen relationships with our shareholders and the investing community."
Unilife also wishes to note the appointment of Mr. Stephen Allan, who has been with the Company since 2002, to the position of Senior Vice President of Strategic Planning.
About Unilife Corporation Unilife Corporation (NASDAQ: UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of injectable drug delivery systems. Unilife's portfolio of innovative, differentiated products includes prefilled syringes with automatic needle retraction, drug reconstitution delivery systems, auto-injectors, wearable injectors, ocular delivery systems and novel systems. Products within each platform are customizable to address specific customer, drug and patient requirements. Unilife's global headquarters and manufacturing facilities are located in York, PA. For more information, visit www.unilife.com or download the Unilife IR app on your iPhone, iPad or Android device.
Forward-Looking Statements This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our Annual Report on Form 10-K and those described from time to time in other reports which we file with the Securities and Exchange Commission.
SOURCE Unilife Corporation